Zervos Michael, Park Bernard J, Marshall M Blair, Wee Jon O, Soukiasian Harmik J, Hartwig Matthew G, Rajaram Ravi, Rice David C
Department of Cardiothoracic Surgery, NYU Langone Health, New York, NY.
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
J Thorac Cardiovasc Surg. 2025 Jul;170(1):54-60.e1. doi: 10.1016/j.jtcvs.2025.04.004. Epub 2025 Apr 9.
To confirm the feasibility and safety of the da Vinci single-port (SP) System to perform pulmonary lobectomy procedures using a subcostal, uniportal approach.
A prospective multicenter, single-arm clinical study evaluating the performance and safety of the da Vinci SP Surgical System for pulmonary lobectomy.
Nineteen subjects (benign, n = 1; malignant, n = 18) were enrolled at 6 academic medical centers in the United States and underwent robotic-assisted SP subcostal lobectomy. All SP lobectomy procedures were completed without conversion to multiport thoracoscopic/robotic or open approaches. No intraoperative adverse events (AEs) or unanticipated adverse device effects were observed; 13 postoperative AEs commonly experienced after lobectomy were reported, 4 of which were Clavien-Dindo grade III. The rate of complete resection (ie, R0) was 100%. The median number of nodal stations sampled was 6.5 (interquartile range [IQR], 6.0-8.0) with a median of 17.5 (IQR, 7.0-34.0) nodes resected per patient.
Robotic SP subcostal lobectomy is feasible and is associated with acceptable perioperative and oncologic quality outcomes. Additional clinical experience and research are needed to determine whether this alternative single incision approach has clinical benefit compared to standard transthoracic, multiport robotic lobectomy.
确认达芬奇单孔(SP)系统采用肋下单孔入路进行肺叶切除手术的可行性和安全性。
一项前瞻性多中心单臂临床研究,评估达芬奇SP手术系统用于肺叶切除的性能和安全性。
在美国6家学术医疗中心招募了19名受试者(良性1例,恶性18例),并接受了机器人辅助的SP肋下肺叶切除术。所有SP肺叶切除手术均未转换为多孔胸腔镜/机器人或开放手术方式。未观察到术中不良事件(AE)或意外的器械不良影响;报告了13例肺叶切除术后常见的术后AE,其中4例为Clavien-DindoⅢ级。完整切除率(即R0)为100%。采样的淋巴结站中位数为6.5(四分位间距[IQR],6.0 - 8.0),每位患者切除的淋巴结中位数为17.5(IQR,7.0 - 34.0)。
机器人SP肋下肺叶切除术是可行的,且围手术期和肿瘤学质量结果可接受。需要更多的临床经验和研究来确定这种替代的单切口方法与标准经胸多孔机器人肺叶切除术相比是否具有临床优势。